Harnessing Digital Health for Enhanced Cancer research and Patient OutcomesDigital health technologies – such as platforms for telemedicine, patient education, health monitoring, and data management – offer transformative potential for cancer research and care. Digital health tools facilitate real-time patient monitoring, improve access to care, and support data-driven decision making. By integrating digital health into … Read more
Appendiceal neoplasms: shedding light on a rare diseaseAppendiceal neoplasms are rare, poorly researched and have a wide range of outcomes. This seminar will discuss the varied subtypes of disease, current treatment options and our research program that aims to better understand the biology, develop useful tumour models and ultimately define new therapeutics. SpeakersA/Prof Kate Mahon. … Read more
Early-onset bowel cancer – detection & treatment gains amid the biggest cancer killer in the under-50sA diagnosis of colorectal cancer is always life-changing, but it is particularly devastating in the under-50s. This seminar will discuss the rising incidence of early colorectal cancer; the evolution of screening recommendations; the utility of advanced surgical options and real-world … Read more
Educational Molecular Tumour Board.The potential role of precision medicine in altering the poor outcomes in pancreas cancer.Pancreatic cancer has a poor prognosis and an urgent need for new effective treatments. In this educational Molecular Tumour Board session, we will hear an update on the molecular features of pancreatic cancer and their relevance to clinical management. … Read more
Liquid Biopsy in CancerLiquid biopsies of blood, urine, or other body fluid such as ascites are gaining interest in cancer diagnostics and treatment. In this session Professor Helen Rizos will discuss liquid biopsies in melanoma – how they can monitor response, predict patient outcomes and current limitations in the application of liquid biopsies and Dr … Read more
Familial Cancer Syndromes and their Clinical ManagementThis webinar draws together interdisciplinary experts to focus on “Familial Cancer Syndromes and Clinical Management”, specifically to increase our understanding of inherited cancer risks and their clinical management skills. Our invited speakers will share insights into the research around the genetic basis of inherited cancer syndromes, including familial breast … Read more
Treatment-induced DNA methylation heterogeneity and implications for cell growth in Acute Myeloid Leukaemia This session will focus on hypomethylating agents (HMAs), which are used to treat people living with acute myeloid leukaemia (AML) and myelodysplasia. While these epigenetic therapies extend survival in many patients, low response rates and therapy-resistant relapse remain significant challenges. Relapse is … Read more
Enhancing HCC Surveillance: A Deep Dive into the Australian Clinical Practice GuidelinesIn this session discover the groundbreaking Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC)surveillance in Australia. Developed alongside a diverse, multi-disciplinary team, these guidelines provide evidence-based recommendations to guide HCC surveillance for individuals at high risk. Don’t miss this opportunity to delve into the world … Read more
Educational Molecular Tumour BoardMelanoma Institute Australia – Personalised Immunotherapy ProgramPlease join us for this Educational Molecular Tumour Board Session with presenters from the Melanoma Institute Australia giving insight into their Personalised Immunotherapy Program. This presentation will cover:– The background around genomic, transcriptomic and tumour immune profiling as biomarkers of response to immunotherapies.– Biomarker multidisciplinary discussion … Read more
“Burning Issues in Radiotherapy Research”This session will provide a great opportunity to explore radiation oncology as a vibrant research sphere that researchers may never have considered before. Hear about the consumer experience, the role of biology in radiation research, the examination of technology and the role of radiation oncology clinical trials. SpeakersAssociate Professor Eric Hau. Radiation … Read more
